To confirmed that GAL-1/LGALS1 promotes the formation of VM in GC through promoting the expression of GLI1, we used GANT61, a GLI1-specific antagonist, to investigate whether GAL-1/LGALS1 promotes VM in GC through activation of the Hh pathway. Here, LGALS1 is linked to gastric cancer.